268 related articles for article (PubMed ID: 16772076)
1. [The effects of different clinicopathologic variables on serum protein fingerprint in hepatocellular carcinoma patients].
Huang C; Fan J; Zhou J; Liu YK; Cui JF
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):445-9. PubMed ID: 16772076
[TBL] [Abstract][Full Text] [Related]
2. [Study of serum proteome biomarkers with relation to the formation of portal vein tumor thrombi in hepatocellular carcinoma patients].
Huang C; Fan J; Zhou J; Liu YK; Cui JF; Kang XN; Yang PY; Tang ZY
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):781-5. PubMed ID: 15949388
[TBL] [Abstract][Full Text] [Related]
3. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
[TBL] [Abstract][Full Text] [Related]
4. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
5. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
[TBL] [Abstract][Full Text] [Related]
6. [Screening low molecular weight protein biomarkers relevant to portal vein tumor thrombi in serum of patients with hepatocellular carcinoma].
Qiu JG; Fan J; Liu YK; Zhou J; Qiu SJ; Dai Z; Kang XN; Huang C; Yang PY; Tang ZY
Zhonghua Gan Zang Bing Za Zhi; 2007 Jul; 15(7):498-502. PubMed ID: 17669237
[TBL] [Abstract][Full Text] [Related]
7. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases.
Paradis V; Degos F; Dargère D; Pham N; Belghiti J; Degott C; Janeau JL; Bezeaud A; Delforge D; Cubizolles M; Laurendeau I; Bedossa P
Hepatology; 2005 Jan; 41(1):40-7. PubMed ID: 15690480
[TBL] [Abstract][Full Text] [Related]
8. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
9. [The effects of portal vein microscopic and macroscopic tumor thrombi on post-operation patients with hepatocellular carcinoma].
Fan J; Tang ZY; Wu ZQ; Zhou J; Zhou XD; Ma ZC; Qin LX; Qiu SJ; Yu Y; Huang C
Zhonghua Wai Ke Za Zhi; 2005 Apr; 43(7):433-5. PubMed ID: 15854367
[TBL] [Abstract][Full Text] [Related]
10. Identification of two portal vein tumor thrombosis associated proteins in hepatocellular carcinoma: protein disulfide-isomerase A6 and apolipoprotein A-I.
Xu X; Wei X; Ling Q; Cheng J; Zhou B; Xie H; Zhou L; Zheng S
J Gastroenterol Hepatol; 2011 Dec; 26(12):1787-94. PubMed ID: 21649721
[TBL] [Abstract][Full Text] [Related]
11. Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma.
Chen XP; Qiu FZ; Wu ZD; Zhang ZW; Huang ZY; Chen YF; Zhang BX; He SQ; Zhang WG
Ann Surg Oncol; 2006 Jul; 13(7):940-6. PubMed ID: 16788755
[TBL] [Abstract][Full Text] [Related]
12. [Percutaneous laser ablation in the treatment of portal vein tumor thrombus in 93 hepatocellular carcinoma patients].
Lu ZH; Shen F; Yuan GX; Shi LH; Zong M; Yang JH; Guo J; Wu MC
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):449-52. PubMed ID: 17974281
[TBL] [Abstract][Full Text] [Related]
13. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
Wu FX; Wang Q; Zhang ZM; Huang S; Yuan WP; Liu JY; Ban KC; Zhao YN
Cancer Lett; 2009 Jul; 279(2):163-70. PubMed ID: 19268439
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin.
Dohmen K; Shigematsu H; Irie K; Ishibashi H
Hepatogastroenterology; 2003; 50(54):2072-8. PubMed ID: 14696467
[TBL] [Abstract][Full Text] [Related]
15. [Expression of tumor metastasis-suppressor gene KiSS-1 and matrix metalloproteinase-9 in portal vein tumor thrombus of hepatocellular carcinoma].
Hou YK; Wang Y; Cong WM; Wu MC
Ai Zheng; 2007 Jun; 26(6):591-5. PubMed ID: 17562263
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors of hepatocellular carcinoma after liver transplantation].
Zhou LX; Yan LN
Ai Zheng; 2006 Jun; 25(6):736-9. PubMed ID: 16764771
[TBL] [Abstract][Full Text] [Related]
17. Liver resection with portal vein thrombectomy for hepatocellular carcinoma with vascular invasion.
Aldrighetti L; Pulitanò C; Catena M; Arru M; Guzzetti E; Halliday J; Ferla G
Ann Surg Oncol; 2009 May; 16(5):1254. PubMed ID: 19277788
[TBL] [Abstract][Full Text] [Related]
18. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus.
Peng ZW; Guo RP; Zhang YJ; Lin XJ; Chen MS; Lau WY
Cancer; 2012 Oct; 118(19):4725-36. PubMed ID: 22359112
[TBL] [Abstract][Full Text] [Related]
19. [Application of SELDI-TOF-MS in detection of liver metastasis from colorectal cancer].
Shi YJ; Zhao Y; Xu JM; Lai YH; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):910-3. PubMed ID: 19173991
[TBL] [Abstract][Full Text] [Related]
20. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
